DSXS topical product

DRUG2 trials

Sponsors

Sun Pharmaceutical Industries, Inc.

Conditions

PsoriasisScalp Psoriasis

Phase 2

Safety Study in Patients With Scalp Psoriasis Suppression Following Maximal Use Treatment With Topical Product

CompletedNCT02933502

Sun Pharmaceutical Industries, Inc.Scalp Psoriasis

Start: 2016-07-11End: 2018-01-02Updated: 2018-12-10

Safety Study to Assess the Potential for Adrenal Suppression Following Maximal Use Treatment With DSXS

CompletedNCT02933528

Sun Pharmaceutical Industries, Inc.Psoriasis

Start: 2016-07-11End: 2017-11-27Updated: 2018-12-06